Distribution of TP53 and FGFR3 somatic mutations in relation to tumor morphology and histology.</p
<p>Distribution of pathogenic/likely pathogenic mutations with respect to family history, age at dia...
a<p>The H506Y mutation is a somatic second-hit observed in FFPE tumor tissue from patient 1884.</p><...
<p>Association between <i>FGFR3</i> and <i>TP53</i> mutations according to the stage/grade group.</p
a. The graphical summary of somatic mutations of the 4 genes in molecular subtypes. All of the 190 t...
<p><i>TP53</i> mutation rates in <i>FGFR3</i>-wild-type and FGFR3-mutated tumours, according to a co...
<p>Sample sizes, somatic mutations and gene expression profiles for three cancers.</p
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>Summary of somatic mutation types and prevalence in early gastric cancers.</p
<p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with mutated <i>...
<p>Sequence positions and frequencies of mutated residues in the FGFR protein are shown. Mutational ...
<p>A. Frequencies of detected mutations in different exons. B. Mutation distribution in exons. C. Mu...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>For each somatic mutation, the percentage of the distance from the start of the 3′UTR to the soma...
<p>Summary of <i>TP53</i> mutations found in B<i>[a]</i>P exposed-cells (Cc: concentration).</p
<p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with <i>FGFR3</i...
<p>Distribution of pathogenic/likely pathogenic mutations with respect to family history, age at dia...
a<p>The H506Y mutation is a somatic second-hit observed in FFPE tumor tissue from patient 1884.</p><...
<p>Association between <i>FGFR3</i> and <i>TP53</i> mutations according to the stage/grade group.</p
a. The graphical summary of somatic mutations of the 4 genes in molecular subtypes. All of the 190 t...
<p><i>TP53</i> mutation rates in <i>FGFR3</i>-wild-type and FGFR3-mutated tumours, according to a co...
<p>Sample sizes, somatic mutations and gene expression profiles for three cancers.</p
<p>Distribution of the number of mutations according to mutational signatures in HR+/HER2− metastati...
<p>Summary of somatic mutation types and prevalence in early gastric cancers.</p
<p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with mutated <i>...
<p>Sequence positions and frequencies of mutated residues in the FGFR protein are shown. Mutational ...
<p>A. Frequencies of detected mutations in different exons. B. Mutation distribution in exons. C. Mu...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>For each somatic mutation, the percentage of the distance from the start of the 3′UTR to the soma...
<p>Summary of <i>TP53</i> mutations found in B<i>[a]</i>P exposed-cells (Cc: concentration).</p
<p>Proportion of tumours with both <i>FGFR3</i> and <i>TP53</i> mutations (orange), with <i>FGFR3</i...
<p>Distribution of pathogenic/likely pathogenic mutations with respect to family history, age at dia...
a<p>The H506Y mutation is a somatic second-hit observed in FFPE tumor tissue from patient 1884.</p><...
<p>Association between <i>FGFR3</i> and <i>TP53</i> mutations according to the stage/grade group.</p